Abstract:Objective: To investigate the clinicopathologic features, molecular characteristics and prognosis of spread through air space (STAS) in patients with adenocarcinoma of the lung. Methods: Two hundred and eighty-eight lung adenocarcinoma patients with complete clinicopathologic and follow-up data were included. The patients were divided into STAS positive (178 cases) and negative (110 cases) groups.EGFR and KRAS gene mutations were detected by amplification refractory mutation system (ARMS), and ALK and ROS1 gene fusion were detected by fluorescence in situ hybridization method. The relationship between STAS and clinicopathologic, molecular features, and patient outcome was analyzed. Results: STAS was present in 61.8%(178/288) of lung adenocarcinomas. The positive rate of STAS in tumors >3 cm was significantly higher than that in tumors ≤3 cm (P=0.009), and was significantly higher in tumors with pleural invasion (P<0.01), venous invasion (P<0.01), lymphatic invasion (P<0.01), perineural invasion (P=0.029) and tumors with necrosis (P<0.01). STAS was also correlated with tumor recurrence (P<0.01) and advanced pathologic TNM stage (P=0.002). There was no significant correlation with patients' gender, age and smoking history. Histologically, STAS was present in 58.0%(91/157), 67.6%(50/74), 2/6, 64.3%(27/42) and 8/9 of acinar, papillary, lepidic, solid and micropapillary adenocarcinomas, respectively. In addition, the positive rates of STAS in tumor with micropapillary (>5%) and without micropapillary pattern were 80.9%(55/68) and 55.9%(123/220), respectively (P<0.01). STAS was significantly higher in EGFR negative group (P=0.034), ALK gene rearrangement group (P=0.003) and ROS1 gene rearrangement group (P=0.012), but there was no significant correlation with KRAS mutation. Univariate survival analysis showed that patients with STAS had a shorter progression-free survival (PFS, P<0.01) and overall survival (P=0.013). Multivariate analysis confirmed that STAS was an independent predictor of PFS in lung adenocarcinoma patients (HR: 2.749, 95%CI: 1.550-4.876, P=0.001). Conclusions: The presence of STAS in lung adenocarcinoma suggests high risk of recurrence and invasion and is thus an important prognostic factor. In addition, STAS is associated with EGFR mutation, ALK and ROS1 gene rearrangement.

PUB019 Preoperative Needle Biopsy and Tumor Spread Through Alveolar Spaces (STAS) in Resected Lung Adenocarcinomas

Impact of preoperative biopsy on tumor spread through air spaces in stage I non-small cell lung cancer: a propensity score-matched study

Histopathologic Features from Preoperative Biopsies to Predict Spread Through Air Spaces in Early Stage Lung Adenocarcinoma: A Retrospective Study

Lobectomy is Associated with Better Outcomes Than Sublobar Resection in Spread Through Air Spaces (Stas)-Positive T1 Lung Adenocarcinoma: A Propensity Score–Matched Analysis

Tumor Spread Through Air Spaces is a Predictor of Occult Lymph Node Metastasis in Clinical Stage IA Lung Adenocarcinoma

MA12.05 Can Tumor Spread Through Air Spaces (STAS) in Lung Adenocarcinomas Be Predicted Pre- and Intraoperatively?

Prognostic Impact of Tumor Spread Through Air Spaces in Sublobar Resection for 1A Lung Adenocarcinoma Patients

Prognostic implication of tumor spread through air spaces in patients with pathologic N0 lung adenocarcinoma

Impact of Surgery and Adjuvant Chemotherapy on the Survival of Stage I Lung Adenocarcinoma Patients with Tumor Spread Through Air Spaces.

Spread Through Air Spaces Predicts a Worse Survival in Patients with Stage I Adenocarcinomas >2 Cm after Radical Lobectomy.

Spread Through Air Spaces (STAS) in Surgically Resected Lung Adenocarcinoma Prognosis

[To Evaluate the Clinicopathologic Characteristics and Outcome of Tumor Cells Spreading Through Air Spaces in Patients with Adenocarcinoma of Lung].

MA12.06 Tumor Spread Through Air Spaces (STAS) in Lung Squamous Cell Cancer is an Independent Risk Factor: A Competing Risk Analysis

Prognostic Significance of Limited Resection in Pathologic Stage I Lung Adenocarcinoma with Spread Through Air Spaces

OA07.06 in Early-Stage Lung Adenocarcinomas, Survival by Tumor Size (T) is Further Stratified by Tumor Spread Through Air Spaces

Significance of Spread Through Air Spaces and Vascular Invasion in Early-stage Adenocarcinoma Survival

Association of Shorter Time to Recurrence and Recurrence-free Survival with Transthoracic Lung Biopsy in Stage I Lung Cancer

Relationship between clinicopathologic characteristics and spread through air spaces in resected lung adenocarcinoma and squamous cell carcinoma cases

Recurrence Risk after Preoperative Biopsy in Patients with Resected Early-Stage Non-Small-cell Lung Cancer: a Retrospective Study

Morphological Subtypes of Tumor Spread Through Air Spaces in Non-Small Cell Lung Cancer: Prognostic Heterogeneity and Its Underlying Mechanism

Retrospective analysis of the prognostic implications of tumor spread through air spaces in lung adenocarcinoma patients treated with surgery